Physician

Harsha Vardhan Poola, M.D

According to 2025 Medicare claims, Harsha Poola, M.D (NPI: 1801174354) practices hematology/oncology in the Appleton, WI market, with the plurality of this provider's patient population coming from Calumet, WI. This provider's primary affiliated billing organization is THEDACARE, INCORPORATED (NPI: 1376656959; TIN: 391509362) and primary practice location at 54911-8735. Poola is affiliated with the THEDACARE ACO (ACO ID: A4988), participating under the MSSP model.

Poola's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 206 traditional Medicare patients, billed 2,154 HCPCS/CPT codes, and received $121,100 in Medicare payments. The top billing code was 78815 (Nuclear medicine study from skull base to mid-thigh with ct scan). Part D data shows 567 prescription claims across 153 beneficiaries totaling $552,336 in drug costs, led by Nubeqa (Darolutamide). 2018 DME data shows 65 claims. Open Payments data shows 2 records totaling $159. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $20,841 and ending at $121,100. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $171,667 and ending at $552,336. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	123	316	$20,841
2018	241	1,040	$61,768
2019	303	1,108	$65,906
2020	96	206	$18,060
2021	91	309	$30,336
2022	115	3,416	$58,110
2023	168	1,721	$57,208
2024	206	2,154	$121,100

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	18	67	$171,667
2016	25	147	$398,693
2017	72	274	$504,765
2018	109	664	$895,173
2019	136	877	$1,806,815
2020	83	340	$191,549
2021	91	384	$348,954
2022	110	510	$299,060
2023	150	546	$331,134
2024	153	567	$552,336

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	65	$5,038
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
78815	Nuclear medicine study from skull base to mid-thigh with ct scan	27	32	$1,130
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	36	36	$150
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	40	46	$129
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	144	246	$88
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	123	207	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Nubeqa	Darolutamide	15	450	$230,454
Eliquis	Apixaban	31	1,545	$29,534
Ondansetron Hcl	Ondansetron Hcl	117	2,100	$3,401
Prochlorperazine Maleate	Prochlorperazine Maleate	113	1,385	$1,961
Dexamethasone	Dexamethasone	50	236	$515

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$159	Novocure Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Harsha Vardhan Poola, M.D?

Tedicare shows public-source Medicare data for Harsha Vardhan Poola, M.D (NPI 1801174354), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Harsha Vardhan Poola, M.D have ACO affiliation data?

Harsha Vardhan Poola, M.D is shown with ACO affiliation data for THEDACARE ACO (MSSP, ACO ID A4988).

What billing organization is linked to Harsha Vardhan Poola, M.D?

Harsha Vardhan Poola, M.D is linked to THEDACARE, INCORPORATED (billing NPI 1376656959) in the available physician profile data.

Does Harsha Vardhan Poola, M.D have Open Payments data?

Harsha Vardhan Poola, M.D has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.